The role of ureteric indocyanine green fluorescence in colorectal surgery: a retrospective cohort study.


Journal

Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614

Informations de publication

Date de publication:
10 Jul 2024
Historique:
received: 01 03 2024
accepted: 08 06 2024
medline: 10 7 2024
pubmed: 10 7 2024
entrez: 10 7 2024
Statut: epublish

Résumé

Ureteric injury (UI) is an infrequent but serious complication of colorectal surgery. Prophylactic ureteric stenting is employed to avoid UI, yet its efficacy remains debated. Intraoperative indocyanine green fluorescence imaging (ICG-FI) has been used to facilitate ureter detection. This study aimed to investigate the role of ICG-FI in identification of ureters during colorectal surgery and its impact on the incidence of UI. A retrospective cohort study involving 556 consecutive patients who underwent colorectal surgery between 2018 and 2023 assessed the utility of routine prophylactic ureteric stenting with adjunctive ICG-FI. Patients with ICG-FI were compared to those without ICG-FI. Demographic data, operative details, and postoperative morbidity were analyzed. Statistical analysis included univariable regression. Ureteric ICG-FI was used in 312 (56.1%) patients, whereas 43.9% were controls. Both groups were comparable in terms of demographics except for a higher prevalence of prior abdominal surgeries in the ICG-FI group. Although intraoperative visualization was significantly higher in the ICG-FI group (95.3% vs 89.1%; p = 0.011), the incidence of UI was similar between groups (0.3% vs 0.8%; p = 0.585). Postoperative complications were similar between the two groups. Median stent insertion time was longer in the ICG-FI group (32 vs 25 min; p = 0.001). Ureteric ICG-FI improved intraoperative visualization of the ureters but was not associated with a reduced UI rate. Median stent insertion time increased with use of ureteric ICG-FI, but total operative time did not. Despite its limitations, this study is the largest of its kind suggesting that ureteric ICG-FI may be a valuable adjunct to facilitate  ureteric visualization during colorectal surgery.

Sections du résumé

BACKGROUND BACKGROUND
Ureteric injury (UI) is an infrequent but serious complication of colorectal surgery. Prophylactic ureteric stenting is employed to avoid UI, yet its efficacy remains debated. Intraoperative indocyanine green fluorescence imaging (ICG-FI) has been used to facilitate ureter detection. This study aimed to investigate the role of ICG-FI in identification of ureters during colorectal surgery and its impact on the incidence of UI.
METHODS METHODS
A retrospective cohort study involving 556 consecutive patients who underwent colorectal surgery between 2018 and 2023 assessed the utility of routine prophylactic ureteric stenting with adjunctive ICG-FI. Patients with ICG-FI were compared to those without ICG-FI. Demographic data, operative details, and postoperative morbidity were analyzed. Statistical analysis included univariable regression.
RESULTS RESULTS
Ureteric ICG-FI was used in 312 (56.1%) patients, whereas 43.9% were controls. Both groups were comparable in terms of demographics except for a higher prevalence of prior abdominal surgeries in the ICG-FI group. Although intraoperative visualization was significantly higher in the ICG-FI group (95.3% vs 89.1%; p = 0.011), the incidence of UI was similar between groups (0.3% vs 0.8%; p = 0.585). Postoperative complications were similar between the two groups. Median stent insertion time was longer in the ICG-FI group (32 vs 25 min; p = 0.001).
CONCLUSION CONCLUSIONS
Ureteric ICG-FI improved intraoperative visualization of the ureters but was not associated with a reduced UI rate. Median stent insertion time increased with use of ureteric ICG-FI, but total operative time did not. Despite its limitations, this study is the largest of its kind suggesting that ureteric ICG-FI may be a valuable adjunct to facilitate  ureteric visualization during colorectal surgery.

Identifiants

pubmed: 38985353
doi: 10.1007/s10151-024-02955-x
pii: 10.1007/s10151-024-02955-x
doi:

Substances chimiques

Indocyanine Green IX6J1063HV
Coloring Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

83

Informations de copyright

© 2024. The Author(s).

Références

Halabi WJ, Jafari MD, Nguyen VQ et al (2014) Ureteral injuries in colorectal surgery: an analysis of trends, outcomes, and risk factors over a 10-year period in the United States. Dis Colon Rectum 57:179–186. https://doi.org/10.1097/DCR.0000000000000033
doi: 10.1097/DCR.0000000000000033 pubmed: 24401879
Luks VL, Merola J, Arnold BN, Ibarra C, Pei KY (2019) Prophylactic ureteral stenting in laparoscopic colectomy: revisiting traditional practice. J Surg Res 234:161–166. https://doi.org/10.1016/j.jss.2018.09.041
doi: 10.1016/j.jss.2018.09.041 pubmed: 30527469
Hird AE, Nica A, Coburn NG, Kulkarni GS, Nam RK, Gien LT (2021) Does prophylactic ureteric stenting at the time of colorectal surgery reduce the risk of ureteric injury? A systematic review and meta-analysis. Colorectal Dis 23:1060–1070. https://doi.org/10.1111/codi.15498
doi: 10.1111/codi.15498 pubmed: 33340227
da Silva G, Boutros M, Wexner SD (2012) Role of prophylactic ureteric stents in colorectal surgery. Asian J Endosc Surg 5:105–110. https://doi.org/10.1111/j.1758-5910.2012.00134.x
doi: 10.1111/j.1758-5910.2012.00134.x pubmed: 22776608
Croghan SM, Zaborowski A, Mohan HM et al (2019) The sentinel stent? A systematic review of the role of prophylactic ureteric stenting prior to colorectal resections. Int J Colorectal Dis 34:1161–1178. https://doi.org/10.1007/s00384-019-03314-1
doi: 10.1007/s00384-019-03314-1 pubmed: 31175421
Nam YS, Wexner SD (2002) Clinical value of prophylactic ureteral stent indwelling during laparoscopic colorectal surgery. J Korean Med Sci 17:633–635. https://doi.org/10.3346/jkms.2002.17.5.633
doi: 10.3346/jkms.2002.17.5.633 pubmed: 12378014 pmcid: 3054949
Leff EI, Groff W, Rubin RJ, Eisenstat TE, Salvati EP (1982) Use of ureteral catheters in colonic and rectal surgery. Dis Colon Rectum 25:457–460. https://doi.org/10.1007/BF02553655
doi: 10.1007/BF02553655 pubmed: 7094783
Bothwell WN, Bleicher RJ, Dent TL (1994) Prophylactic ureteral catheterization in colon surgery. A five-year review. Dis Colon Rectum 37:330–334
doi: 10.1007/BF02053592 pubmed: 8168411
Mensah J, Klufio G, Ahiaku F, Osafo C, Gepi-Attee S (2008) Delayed recognition of bilateral ureteral injury after gyneacological surgery. Ghana Med J 42:133–136
pubmed: 19452019 pmcid: 2673835
Emile SH, Khan SM, Wexner SD (2022) Impact of change in the surgical plan based on indocyanine green fluorescence angiography on the rates of colorectal anastomotic leak: a systematic review and meta-analysis. Surg Endosc 36:2245–2257. https://doi.org/10.1007/s00464-021-08973-2
doi: 10.1007/s00464-021-08973-2 pubmed: 35024926
Emile SH, Elfeki H, Shalaby M et al (2017) Sensitivity and specificity of indocyanine green near-infrared fluorescence imaging in detection of metastatic lymph nodes in colorectal cancer: systematic review and meta-analysis. J Surg Oncol 116:730–740. https://doi.org/10.1002/jso.24701
doi: 10.1002/jso.24701 pubmed: 28570748
Satish VNVR, Acharya A, Ramachandran S, Narasimhan M, Ardhanari R (2022) Fluorescent ureterography with indocyanine green in laparoscopic colorectal surgery: a safe method to prevent intraoperative ureteric injury. J Minim Access Surg 18:320–323. https://doi.org/10.4103/jmas.jmas_183_21
doi: 10.4103/jmas.jmas_183_21
Yeung TM, Volpi D, Tullis ID et al (2016) Identifying ureters in situ under fluorescence during laparoscopic and open colorectal surgery. Ann Surg 263:e1–e2
doi: 10.1097/SLA.0000000000001513 pubmed: 26672509
White LA, Joseph JP, Yang DY et al (2021) Intraureteral indocyanine green augments ureteral identification and avoidance during complex robotic-assisted colorectal surgery. Colorectal Dis 23:718–723. https://doi.org/10.1111/codi.15407
doi: 10.1111/codi.15407 pubmed: 33064915
Mandovra P, Kalikar V, Patankar RV (2019) Real-time visualization of ureters using indocyanine green during laparoscopic surgeries: can we make surgery safer? Surg Innov 26:464–468. https://doi.org/10.1177/1553350619827152
doi: 10.1177/1553350619827152 pubmed: 30734638
Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transpl 48:452–458. https://doi.org/10.1038/bmt.2012.244
doi: 10.1038/bmt.2012.244
Yanagisawa T, Mori K, Quhal F et al (2022) Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta-analysis. BJU Int 131:540–552. https://doi.org/10.1111/bju.15913
doi: 10.1111/bju.15913 pubmed: 36196670
Alexandre AF, Kimura T, Feng Q et al (2023) Effectiveness and cost of stenting in ureteral injury in colorectal surgeries in the US: 2015–2019. JSLS 27(e2023):00023. https://doi.org/10.4293/JSLS.2023.00023
doi: 10.4293/JSLS.2023.00023
Siddighi S, Yune JJ, Hardesty J (2014) Indocyanine green for intraoperative localization of ureter. Am J Obstet Gynecol 436:e1–e2
Lee Z, Moore B, Giusto L, Eun DD (2015) Use of indocyanine green during robot-assisted ureteral reconstructions. Eur Urol 67:291–298
doi: 10.1016/j.eururo.2014.08.057 pubmed: 25220372
Lee Z, Kaplan J, Giusto L, Eun D (2016) Prevention of iatrogenic ureteral injuries during robotic gynecologic surgery: a review. Am J Obstet Gynecol 214:566–571
doi: 10.1016/j.ajog.2015.10.150 pubmed: 26519785
Mahalingam SM, Dip F, Castillo M et al (2018) Intraoperative ureter visualization using a novel near-infrared fluorescent dye. Mol Pharm 15:3442–3447. https://doi.org/10.1021/acs.molpharmaceut.8b00427
doi: 10.1021/acs.molpharmaceut.8b00427 pubmed: 29979605

Auteurs

P Rogers (P)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

J Dourado (J)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

A Wignakumar (A)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

B Weiss (B)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

P Aeshbacher (P)

Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Z Garoufalia (Z)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

V Strassmann (V)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

S Emile (S)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.
Colorectal Surgery Unit, General Surgery Department, Mansoura University Hospitals, Mansoura, Egypt.

P Strzempek (P)

Ross University School of Medicine, Miramar, USA.

S Wexner (S)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA. Wexners@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH